alexa Thioridazine: A Therapeutic Panacea for Efflux Pump

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Thioridazine: A Therapeutic Panacea for Efflux Pump

It is estimated that most of the medicinal compounds developed during the 20th century have their origins in phenothiazines [1]. Among these medicinal compounds is the first neuroleptic chlorpromazine (CPZ) introduced in 1957. The wide use of CPZ resulted in many published observations that indicated activity against a wide variety of microorganisms that cause therapeutically problematic infections [2]. CPZ has been shown to have in vitro activity against antibiotic susceptible [3] and resistant strains of Mycobacterium tuberculosis [4], has cured the aortis monkey of an antibiotic resistant malaria infection [5] and has yielded a temporary cure of prion promoted CJD [6].

Citation: Leonard Amaral (2015) Thioridazine: A Therapeutic Panacea for Efflux Pump Mediated Multidrug Bacterial Infections. J Biomol Res Ther 4:123.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger